Clinical Trial Update: Cannabidiol for Pain Relief of Patients With End-stage mCRPC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Regionshospital Nordjylland is evaluating cannabidiol for pain relief in patients with metastatic castration-resistant pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Regionshospital Nordjylland | Conditions: Metastatic Castration Resistant Prostate Cancer (mCRPC) | Phase 2 | Status: NOT_YET_RECRUITING